21 March 2013
SCI's Young Chemists Panel
University of Cambridge
This event is no longer available for registration.
The area of structure-based drug design is focused on achieving stabilising and selective interactions between the ligand and the protein binding site. An understanding of how interactions behave in 3D and their relative energetics is therefore highly beneficial when assessing potential candidate molecules.
This one day event has been developed to address the area of molecular interactions and will provide the participants with a solid understanding of the various types of common interaction and how they are relevant in drug discovery. Lectures will be delivered by leading experts in the field, and topics will include the preferred geometries and energetics of interactions (such as hydrogen-bonds, aromatic interactions and halogen bonds) as well as bioisosterism and how to evaluate whether an observed interaction is important or not.
University of CambridgePfizer Lecture Theatre, University of Cambridge, UK
SCI Conference Team
Tel: +44 (0)20 7598 1561
Earlybird fees - before 8 February 2013
GB£75 . . . . . . . . . .SCI Member
GB£25. . . . . . . . . . SCI Student
GB£100 . . . . . . . . .Non Member
Standard fees - after 8 February 2013
GB£90 . . . . . . . . . .SCI Member
GB£30 .. . . . . . . . . SCI Student
GB£120 . . . . . . . . .Non Member
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
SCI Members attending this meeting are able to claim CPD points.
Pete Wood, Cambridge Crystallographic Data Centre
John Caldwell, Institute of Cancer Research
Will Farnaby, Takeda
Jamie Scott, AstraZeneca
Tom Sheppard, University College London